期刊文献+

尿系列蛋白检测在无症状高尿酸血症肾损害早期诊断中的价值 被引量:2

Significance of the Urine Protein Detecting in the Initial Diagnosis of Asymptomatic Hyperuricemia Injury of Kidney Patients
下载PDF
导出
摘要 目的:探讨尿中微量白蛋白(MA)、α1-微球蛋白(A1M)、免疫球蛋白(IGU)和转铁蛋白(TRU)对无症状性高尿酸血症引起肾损害早期诊断的价值。方法:利用速率散射免疫比浊法测定了85例高尿酸血症患者和53例健康人的晨尿中四种尿微量蛋白的含量。结果:无症状高尿酸血症患者四种微量蛋白的水平显著高于正常对照者水平(P<0.01),无症状高尿酸血症尿MA、A1M、IgU、TRU的异常率分别为32.9%、36.5%、10.5%、44.7%;且与患者年龄、血尿酸水平密切相关。结论:MA、A1M、IgU、TRU是诊断无症状高尿酸血症早期肾损害的敏感指标,其中以TRU最敏感,联合测定尿MA、A1M、IgU、TRU有助于无症状高尿酸血症早期肾损害的诊断。 Objective To investigate the significance of microprotein(MA),α-microprotein(A1M) immunoglobulin(IgU) andtransferrin(TRU) in diagnosing the initial renal injury in asymptomatic hyperuricemia patients.Methods MA,A1M,IGU and TRU from 85 hyperuricemia patients and 53 healthy comparisons were measured by rate nephelometry.Results MA,A1M,IGU and TRU in asymptomatic hyperuricemia patients were significantly higher than that in 50 healthy comparisons(P<0.01).The abnormity rate of MA,A1M,IGU and TRU in asymptomatic hyperuricemia are separately 32.9%,36.5%,10.5%,44.7%;it is related to the patient age and the level of the blood uric acid closely.Conclusion MA,A1M,IgU and TRU are sensitive indexes in diagnosing the initial renal injury in asymptomatic hyperuricemia,and the most sensitive is TRU,MA,A1M,IGU and TRF can help to diagnose the initial renal injury in asymptomatic hyperuricemia patients.
作者 杨燕
出处 《实用医技杂志》 2007年第7Z期2682-2684,共3页 Journal of Practical Medical Techniques
关键词 微量蛋白 Α1-微球蛋白 免疫球蛋白 转铁蛋白 高尿酸性肾损害 MA A1M IGU TRU Hyperuricemia injury of kidney
  • 相关文献

参考文献8

二级参考文献17

  • 1宁光,郭冀珍.微量蛋白尿诊断早期糖尿病性肾病[J].上海第二医科大学学报,1993,13(2):164-167. 被引量:2
  • 2张桂生,刘国明,王心鸿,孙敏.尿微量白蛋白ELISA测定法及其临床应用[J].上海免疫学杂志,1993,13(5):299-302. 被引量:15
  • 3傅秀兰,陈庆荣,江永娣,董德长,陈明伟,林爱华,王桂兰.尿微量蛋白测定对肾脏病的临床意义[J].上海医学,1993,16(8):462-463. 被引量:20
  • 4李稻.尿系列蛋白的免疫学检测及其临床意义[J].上海医学检验杂志,1996,11(4):251-252. 被引量:65
  • 5[1]Kanauchi M,Nishika H,Hashimoto T,et al.Diagnostic significance of urinary transferrin in diabetic nephropathy.Nippon Jinzo Gakkai Shi,1995,37:649-654.
  • 6[2]Magnotti RA,Patrick Eberly J,Khoury PR, et al.Profile of renal permselectivity by stimultaneous enzyme-linked immuno-sorbent assay of albumin, transferrin,IgG and almicroglobulin with a new microplate reader.Clin Chem,1992,38:636-641.
  • 7[3]Makino H,Ikeda S,Haramoto T, et al.Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.Nephron,1992,61:415-421.
  • 8[1]祝惠民,黄齐,孙人杰,等.内科学[M].第3版.北京:人民卫生出版社,2000,283~302.
  • 9[4]Mogensen CE,keane WF, Bennett PH,et al.Prevention ofdiabetic renal disease with special reference to microalb uminuria[J].Lancet,1995;346(8982):1080~4.
  • 10[6]Cheung CK,Cockram CS,Yeung VT,et al.Unary excretion of trasfirrin by NIDD:a marker for early complications[J].Clin chem,1989;35(8):1672.

共引文献68

同被引文献23

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部